Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EHMT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | EHMT2 |
| Full Name | Euchromatic Histone Lysine Methyltransferase 2 |
| Protein Type | Transferase |
| Function | EHMT2 (also known as G9a or KMT1C) is a histone lysine methyltransferase that catalyzes the mono- and dimethylation of histone H3 at lysine 9 (H3K9me1/2). |
| Primary Expression | Purkinje cells - Allen Brain Atlas: [EHMT2 expression data](https://human |
| Pathways | Apoptosis, apoptosis pathway |
| Ensembl ID | ENSG00000108799 |
| GeneCards | EHMT2 |
| Human Protein Atlas | EHMT2 |
| H3K9 Methylation | Adds H3K9me1/2 marks associated with gene silencing |
| H3K27 Methylation | Can also methylate H3K27 |
| Non-histone Targets | Methylates various non-histone proteins including TP53, RELA, and WIZ |
| Associated Diseases | ALS, Lymphoma |
| Known Drugs/Compounds | Cinobufagin |
| Interactions | JUN, CASPASE3, FOXO1, SIRT1, HDAC1, APOPTOSIS |
| KG Connections | 69 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
EHMT2["<b>EHMT2</b>"]
Cancer{"Cancer"}
EHMT2 -->|"inhibits"| Cancer
Als{"Als"}
EHMT2 -->|"inhibits"| Als
Aging{"Aging"}
EHMT2 -->|"inhibits"| Aging
Lymphoma{"Lymphoma"}
EHMT2 -->|"associated with"| Lymphoma
Ms{"Ms"}
EHMT2 -->|"inhibits"| Ms
Heart_Failure{"Heart Failure"}
EHMT2 -->|"inhibits"| Heart_Failure
EHMT2 -->|"activates"| Aging
EHMT2 -->|"activates"| Als
EHMT2 -->|"activates"| Cancer
EHMT2 -->|"activates"| Heart_Failure
EHMT2 -->|"therapeutic target"| Aging
EHMT2 -->|"therapeutic target"| Ms
BAX["BAX"]
BAX -->|"associated with"| EHMT2
FOXO1["FOXO1"]
FOXO1 -->|"associated with"| EHMT2
JUN["JUN"]
JUN -->|"inhibits"| EHMT2
BCL_2["BCL-2"]
BCL_2 -->|"associated with"| EHMT2
BCL2["BCL2"]
BCL2 -->|"associated with"| EHMT2
KDM1A["KDM1A"]
KDM1A -->|"therapeutic target"| EHMT2
HDAC2["HDAC2"]
HDAC2 -->|"therapeutic target"| EHMT2
DNMT1["DNMT1"]
DNMT1 -->|"therapeutic target"| EHMT2
AND["AND"]
AND -->|"associated with"| EHMT2
CASPASE8["CASPASE8"]
CASPASE8 -->|"associated with"| EHMT2
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"inhibits"| EHMT2
style EHMT2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| FOXO1 | inhibits | gene | 0.85 |
| cell proliferation | promotes | process | 0.80 |
| Cancer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Lymphoma | associated_with | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Heart Failure | inhibits | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Heart Failure | activates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| JUN | inhibits | gene | 0.60 |
| FOXO1 | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| EP300 | therapeutic_target | gene | 0.60 |
| CASPASE3 | associated_with | gene | 0.60 |
| BAX | associated_with | gene | 0.60 |
| CASPASE8 | associated_with | gene | 0.60 |
| FOXO1 | interacts_with | gene | 0.60 |
| SIRT1 | inhibits | gene | 0.60 |
| HDAC1 | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| Apoptosis | inhibits | pathway | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| AMPK | therapeutic_target | gene | 0.60 |
| Epigenetic | therapeutic_target | pathway | 0.60 |
| Insulin Signaling | therapeutic_target | pathway | 0.60 |
| Notch | therapeutic_target | pathway | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| BCL-2 | associated_with | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| B Cell | inhibits | cell_type | 0.60 |
| Caspase | associated_with | protein | 0.60 |
| Raf | inhibits | protein | 0.60 |
| Ras | associated_with | protein | 0.60 |
| apoptosis pathway | participates_in | pathway | 0.60 |
| ALS | associated_with | disease | 0.60 |
| HDAC | inhibits | gene | 0.60 |
| PCNA | interacts_with | gene | 0.60 |
| epigenetic regulation | participates_in | pathway | 0.60 |
| B Cell | expressed_in | cell_type | 0.55 |
| CASPASE3 | interacts_with | protein | 0.50 |
| HDAC1 | co_expressed_with | protein | 0.50 |
| SIRT1 | co_expressed_with | gene | 0.50 |
| FOXO1 | co_expressed_with | gene | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Cinobufagin | inhibits | compound | 0.90 |
| BAX | associated_with | gene | 0.60 |
| FOXO1 | associated_with | gene | 0.60 |
| JUN | inhibits | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| KDM1A | therapeutic_target | gene | 0.60 |
| HDAC2 | therapeutic_target | gene | 0.60 |
| DNMT1 | therapeutic_target | gene | 0.60 |
| CASPASE8 | associated_with | gene | 0.60 |
| CASPASE3 | associated_with | entity | 0.60 |
| BCL-2 | associated_with | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| FOXO1 | interacts_with | gene | 0.50 |
| BCL2 | interacts_with | gene | 0.50 |
| PCNA | interacts_with | protein | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||